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Objectives:  Opioid  overdose  is  still the ﬁrst  cause  of  preventable  death  among  young  men  in Barcelona.
Sound  knowledge  of  opioid  overdose  prevention  is important  to avoid  complications  and deaths.  This
study  aimed  to identify  the factors  associated  with  limited  knowledge  of overdose  prevention  and  to
assess  the  possible  effect  of treatment  and  overdose  prevention  training  programs  on  this  variable.
Methods:  From  October  2008  to March  2009,  current  injecting  opioid  users  attending  harm  reduction
centers  in  Catalonia  (Spain)  were  interviewed.  Crude  and  adjusted  prevalence  ratios  of limited  knowl-
edge about  overdose  prevention  were calculated  by  adjusting  Poisson  regression  models  with  a robust
variance.
Results:  In this  sample,  28.7%  of clients  had  limited  knowledge  of  overdose  prevention.  Factors  associated
with  limited  knowledge  were  country  of  origin,  never  having  received  treatment  for drug  dependency,
having  a low  educational  level,  and  never  having  experienced  an  overdose.  In contrast,  treatment  at the
time  of  the  interview  was  not  associated  with  a  lower  prevalence  of  limited  knowledge  about  overdose
prevention.
Conclusions:  These  ﬁndings  suggest  that preventive  programs  would  beneﬁt  from  accounting  for  linguis-
tic  and  educational  limitations  and  from  participation  in every  treatment  episode.  Comprehensiveness
and  broad  coverage  of such  programs  could  help  to  maximize  their  impact.
©  2013  SESPAS.  Published  by Elsevier  España,  S.L.  All rights  reserved.
La  prevención  de  sobredosis  en  usuarios  de  opioides  por  vía  parenteral:
el  papel  del  tratamiento  y  de  los  talleres  de  prevención
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Objetivos:  La  sobredosis  por  opioides  sigue  siendo  la  primera  causa  de  muerte  prevenible  entre  hombres
jóvenes  en  Barcelona.  El  conocimiento  profundo  acerca  de  la  prevención  de  sobredosis  es importante  a
ﬁn  de  evitar  complicaciones  y muertes.  Los  objetivos  de  este  estudio  fueron  la  identiﬁcación  de  aquellos
factores  asociados  a un  conocimiento  limitado  acerca  de la  prevención  de  sobredosis,  y la evaluación
del posible  efecto  sobre  dicha  variable  del  tratamiento  y  de  la  asistencia  a talleres  de  prevención  de
sobredosis.
Métodos:  Estudio  transversal,  mediante  encuesta  a  usuarios  de  opioides  por  vía  parenteral  que  acudieronentros de tratamiento por usoe sustancias a centros  de  reducción  de  dan˜os  de  Catalun˜a  entre  octubre  de  2008  y marzo  de  2009.  Se obtuvieron  ratios
de prevalencia  crudas  y  ajustadas  de Conocimiento  limitado  sobre  prevención  de  sobredosis  mediante  la
realización  de  modelos  de  regresión  de  Poisson  con  varianza  robusta.
Resultados:  El  28,7%  de  los usuarios  entrevistados  presentaba  Conocimiento  limitado  sobre  prevención
de  sobredosis.  Los  factores  asociados  a dicho  Conocimiento  limitado  fueron  el país  de  origen,  no  haber
recibido tratamiento  por  el consumo  de  drogas,  tener  un menor  nivel  educativo,  y  nunca  haber  sufrido
una  sobredosis.  El  hecho  de  estar  en  tratamiento  en el momento  de  la  entrevista  no se  asoció  a una  menor
prevalencia  de  conocimiento  limitado  sobre  prevención  de  sobredosis.
Abbreviations: EU, European Union; IDU, Injected Drug User; PR, Prevalence Ratio.
∗ Corresponding author.
E-mail address: aespelt@aspb.cat (A. Espelt).
213-9111/$ – see front matter © 2013 SESPAS. Published by Elsevier España, S.L. All rights reserved.
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Conclusiones:  Estos  hallazgos  sugieren  que  los programas  de  prevención  de sobredosis  se  verían  beneﬁcia-
dos  por  tener  en  cuenta  posibles  limitaciones  lingüísticas  y educacionales,  así  como  por  estar  integrados  en
todos  los  episodios  de tratamiento.  La exhaustividad  y  una  cobertura  elevada  pueden  ayudar  a maximizar
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Overdose is a major cause of avoidable death among young
eople, and the main cause of death among injecting drug users
IDUs). Overdose accounts for about 6500 deaths per year in the
uropean Union (EU).1 In Spain, injected opioid use has progres-
ively declined due to the HIV/AIDS epidemic, as well as to cultural
nd market changes.2 However, Catalonia, an autonomous region
ithin Spain, still presents a relatively high proportion of injecting
eroin users, as compared with the rest of the country.3
Opioid overdose can be fatal or non-fatal, and both can be pre-
ented. Non-fatal overdose is very frequent among opioid users,
ith an annual prevalence ranging from 9 to 22%.4,5 Opioid over-
ose can be prevented by avoiding certain risk factors and risky
ehaviors, such as combining heroin with other drugs, especially
entral nervous system depressants, and resuming heroin use
fter an abstinence period. Opioid users employing the injected
oute of administration are at higher risk of suffering an over-
ose than those using other administration routes.4,6 Other risk
actors for suffering an opioid overdose have been extensively
escribed elsewhere.4,7–10 Once an overdose does occur, witnesses
ay  engage in certain interventions to minimize its consequences,
uch as searching for help and responding to overdose.8,11–15 Most
verdose-related deaths occur in the presence of others, frequently
ther opioid users. The prevention of fatal consequences of an over-
ose depend at least partially on how rapidly medical assistance
s provided.16,17 Preventive programs aim to increase knowledge
bout overdose risk factors, enhance recognition of an overdose,
nd train in ﬁrst aid techniques and in the use of naloxone (an opi-
id antagonist which can safely and effectively revert overdoses).14
owever, various interventions are needed at several levels (indi-
idual, community, service providers, and society as a whole) in
rder to have a signiﬁcant impact in reducing the level of fatal
verdose.18
The present study focuses on self-reported knowledge about
verdose prevention among injecting opioid users attending harm
eduction centers in Catalonia. It aims to quantify the level of
nowledge about overdose prevention in injecting opioid users, to
ssess to what extent do treatment episodes and overdose preven-
ion training programs affect this level of knowledge, and to identify
hich other factors are associated with limited knowledge about
verdose prevention in this population.
ethods
tudy design and Subjects
Between October 2008 and March 2009, injecting drug users
ttending harm reduction centers in Catalonia (Spain) were inter-
iewed. Inclusion criteria were having used opioids (heroin,
ethadone or other opioids) and injecting any drug in the 6 months
rior to the interview, and having signed an informed consent form.
his informed consent form clearly stated the conﬁdentiality of the
tudy. The 18 Harm reduction centers included needle exchange
rograms, outreach programs, and three supervised injecting facil-
ties. Most harm reduction centers included in the study (11 out of
8) were located in Barcelona or in its metropolitan area. A con-
enience stratiﬁed sample of injecting opioid users was selecteds.
ESPAS.  Publicado  por Elsevier  España,  S.L.  Todos  los  derechos  reservados.
(n = 729).19 Assignment to strata was proportional to the volume
of visits in each center and to the percentage of individuals in each
center by country of birth. In centers with less than 5% foreign-born
clients, only native participants were recruited. Participants were
randomly selected within harm reduction centers.
Data Collection
Face to face interviews were conducted in each center by
trained interviewers using an anonymous structured question-
naire, adapted from the Itinere3 and World Health Organization20
questionnaires. Information was  collected on socio-demographic
variables, patterns of drug use, use of social and health services,
and non-fatal opioid overdoses. The questionnaire was provided in
4 languages (Spanish, Romanian, English, and French), and piloted
with a group of 15 IDUs from several countries before its adminis-
tration. Interviewers were weekly monitored to control the quality
of data collection.
Overdose was deﬁned as an episode occurring due to heroin,
methadone or other opioids use, in which after drug use, extreme
difﬁculty in breathing, loss of consciousness and problems waking
up or recovering consciousness, and sometimes bluish skin or lips
would appear.21 Participants were asked, in two open ended ques-
tions, to list the three main reasons for an overdose to occur, as
well as the three main actions to undertake in case of witnessing
an overdose. Respondents received 24D to encourage participation.
The study protocol of the REDAN study was approved by an Ethics
Committee Review Board (Hospital Universitari Germans Trias i
Pujol, Badalona, Spain).
Variables
Dependent variable
Reasons and actions cited in each open ended question were
collected as transcribed verbatim and, based on similar underlying
concepts, were classiﬁed in 11 recoded reasons (of which 9 were
risk factors and 2 were inadequate reasons) and 15 recoded actions
(9 recommended actions and 6 inadequate actions). Adequacy was
based on the literature;7,8,10,12 see all categories and example ver-
batim in Table 1. This classiﬁcation was reviewed and agreed upon
separately by three experienced researchers (co-authors MTB -M.D.
PhD-, ASR –MPH PhD, C.V -M.D. PhD-). A regional working docu-
ment was used to resolve inconsistencies.22 Two variables were
created, “Reasons to suffer an overdose”, and “Actions to undergo
if witnessing another person suffering an overdose”.
The dependent variable “Limited knowledge about overdose
prevention” was  created by grouping categories of recoded rea-
sons and actions. When a participant mentioned a maximum of
2 items (including evidence-based risk factors and adequate
actions), he/she was considered to present “limited knowledge
about overdose prevention”.
Independent variables
To assess the effect of treatment and training episodes intheir level of knowledge about overdose prevention, participants
were asked whether they were receiving treatment for their
drug dependency at the time of the interview, and whether they
had ever undergone treatment. Drug dependency treatment
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Table 1
Concepts included in each category of recoded answers to open-ended questions (OEQs). 1A) Answers to the OEQ: “List the three main reasons for overdose you can think
of”.  1B) Answers to the OEQ: “List the three main actions to undertake in case of witnessing an overdose in a peer”.
1A) Reasons to suffer an overdose Category Concepts included
Adequate reasons (known Risk Factors) Amount More heroin than usual
Two  doses in a short time
Use of heroin together with other drugs Mix  with alcohol, benzodiazepines
Mix  with cocaine
Mix  with other drugs
Stronger or purer than usual Purer heroin than usual
Stronger heroin than usual
Low tolerance to heroin Resume injection after abstinence
Resume injection after prison
Lose tolerance and resume heroin use
Health causes Weakness
Predisposition
AIDS
Other pathologies
Injecting route Inject heroin
Injecting whole dose at once/very quickly Inject whole dose at once
Inject dose very quickly
No testing
Psychological problems/suicide attempt Psychological problems
Mental health
Suicide attempt
Change drug supplier New drug supplier
Inadequate reasons Adulterated or cut heroin Drug being adulterated
Cutting substance
Meaningless/false causes (examples) We deserve it
Bad luck
1B) Actions if witnessing an overdose Category Concepts included
Adequate actions (Recommendations) Call emergency services Call an ambulance
Call health emergency
First aid Mouth-to-mouth resuscitation
Cardiopulmonary resuscitation (CPR)
Recovery position
Wake up/Keep awake Wake him/her up
Do not allow falling asleep
Assessment Check if person is conscious
Check pulse
Check pupils
Call  police/call for help Call police
Call friends or relatives asking for help
Search for help
Naloxone Inject naloxone
Inject antidote
Observation Observe him/her
Stay next to him/her
Facilitate breathing Make sure airway is clear
Loosen tight clothes
Remove syringe Remove syringe
Inadequate actions Shower Shower person
Put him/her in the bathtub
Hit  Hit him/her violently
Shake him/her violently
Make the person move/stand up Make him/her run or walk
Help him/her stand up
Inject substance other than naloxone Inject saline
Inject citric
Inject cocaine
Abandon him/her I leave the place of the event
ions (
i
a
d
c
e
g
o
(
BMeaningless act
ncluded drug-free residential treatment or admission in ther-
peutic communities, in-hospital detoxiﬁcation, out-patient
rug-free treatment, methadone maintenance, and other medi-
ation/other treatments. Participants were also asked if they had
ver attended overdose prevention training courses.
Socio-demographic information was collected. Cultural and lan-
uage background was accounted for by regrouping countries
f birth in three categories: native (Spanish), Eastern European
or former Soviet Republic countries; Georgia, Romania, Russia,
ulgaria, the former Yugoslavian countries, Albania, Armenia,I  leave him/her alone
Examples) I laugh at him/her
I panic
Belarus, Lithuania, Poland, Czech Republic, and Ukraine), and other
countries (a heterogeneous category including EU-15 and other
Western European, African, Asian, and American countries). See
Table 2 for a complete listing of explicative variables included in
this study.Statistical analyses
Proportions were calculated in relation to those who  answered
each question for the total sample and separated by sex. The
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Table  2
General characteristics of opioid injectors recruited in Catalonian harm reduction centres, 2008-2009.
Men  Women  Total
n % n % n %
Age
31 or older 468 78.5 89 71.2 557 77.3
Educational level
Secondary or higher 449 75.2 95 74.8 544 75.1
Country of birth*
Other countries 113 18.8 15 11.8 128 17.6
Eastern Europe 156 26.0 20 15.8 176 24.2
Native (Spain) 332 55.2 92 72.4 424 58.2
Age  at ﬁrst injection
Older than 20 268 44.7 49 38.6 317 43.6
Residencea
Institutions or homeless (vs. ﬁxed residence) 244 40.9 42 33.9 286 39.7
Irregular income (marginal activities)a *
Yes 354 59.3 94 74.0 448 61.9
Self-perceived healthb
Bad (vs. good or regular) 224 37.6 52 41.6 276 38.3
Length of illicit drug use
More than 5 years 496 83.6 103 82.4 599 83.4
Time  of last drug injection
previous 30 days 557 92.7 116 91.3 673 92.4
previous 6 months 44 7.3 11 8.7 55 7.6
Frequency of drug injectiona
Daily 306 50.9 59 46.5 365 50.1
Weekly or less 295 49.1 68 53.5 363 49.9
Supervised Injecting Facilitya
Less than half of injection days 267 47.1 59 51.3 326 47.8
Poly-drug usea (NOT tobacco/alcohol)
3 or more drugs 570 94.8 124 97.6 694 95.3
Lifetime overdose
No 269 44.9 62 48.8 331 45.6
Lifetime overdose (n)
None 269 44.9 62 48.8 331 45.6
between 1 and 5 262 43.7 52 41.0 314 43.2
6  or more 68 11.4 13 10.2 81 11.2
Currentb drug dependency treatment
No 310 51.6 56 44.4 366 50.3
Lifetime drug dependency treatment
No 87 14.5 12 9.5 99 13.6
Lifetime overdose prevention courses
No 443 74.1 86 67.7 529 73.0
a Previous 6 months.
b At time of interview.
p
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a* Signiﬁcant p-value (<0.05).
roportion of cases citing each reason and action category was
alculated per country of birth.
The association between limited knowledge about overdose
revention and a set of explanatory variables was  examined using
ivariate and multivariate methods. In bivariate methods sta-
istical signiﬁcance of differences in the prevalence of limited
nowledge was tested using the Chi-square test, rejecting the
ull hypothesis when p < 0.05. In multivariate analysis differ-
nt Poisson regression models with robust error variance were
tted,23 obtaining Prevalence Ratios (PRs) and 95% conﬁdence
ntervals. Finally, a multivariate Poisson regression model with
obust variance (backward model) was ﬁtted, obtaining adjusted
Rs. All variables were included in the ﬁrst model and rejected
n a stepwise way, according to statistical signiﬁcance. Sex and
ge were retained in the model despite not reaching statisticalsigniﬁcance. Statistical analyses were performed using Stata
11.0.
Results
General characteristics of the sample
The study included 729 participants, of which 379 were
recruited within the city of Barcelona. The sample was 82.6% male,
median 36 years of age (20-59 years). Most participants had com-
pleted secondary education (Table 2). There were no statistically
signiﬁcant differences in most characteristics by sex, with the
exceptions of having received most of their income in the previous
6 months from irregular or marginal activities and being immi-
grant. The vast majority of participants had injected drugs during
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eigure 1. Distribution of opioid injectors recruited in Catalonian harm reduction c
verdose cited, and by country of birth (%).
he previous month, but only half of them injected drugs on a daily
asis. In the previous 6 months, almost all participants were using
t least 3 different drugs (95.3%) and had used syringe exchange
rograms (95.6%; data not shown). Most participants had at some
oint in their lives received drug dependency treatment (86.4%),
nd half underwent treatment at the time of the interview (49.7%),
ut only 27% had ever attended overdose prevention courses.
revalence of Limited Knowledge about Overdose Prevention
nd associated factors
Overall, 28.7% of participants had limited knowledge about
verdose prevention, since they could not cite more than two
isk factors and/or adequate actions to undertake if witnessing an
verdose. When separated by origin, 25.7% of native respondents
resented limited knowledge, versus 40.4% of participants from
astern Europe and 22.6% among participants from other countries
Figure 1). Differences in prevalence of limited knowledge were sig-
iﬁcant when comparing native and Eastern Europeans (p < 0.001)
s well as when comparing Eastern Europeans with immigrants
rom other countries (p < 0.01).
Crude prevalence of limited knowledge about overdose preven-
ion was signiﬁcantly higher in people who came from Eastern
uropean countries, were not receiving or had never received drug
ependency treatment, never had suffered an overdose, never had
ttended overdose prevention courses, injected drugs on a daily
asis, or had better or similar self-perceived health than their age
eers (Table 3). Use of supervised injecting facilities was not signif-
cantly associated with knowledge about overdose prevention.
After adjusting for other factors, those participants with pri-
ary or lower educational level (PR = 1.50, 95% CI:1.16-1.94),
oming from Eastern European countries (PR = 1.71, 95%CI:
.29-2.26), never having undergone drug dependency treat-
ent (PR = 1.52, 95% CI:1.17-1.99) and never having suffered an
verdose (PR = 1.37, 95% CI:1.07-1.75) had higher probability of
resenting limited knowledge about overdose prevention (Table 3).
elf-Perceived General Reasons for Overdose and Actions in Case
f Witnessing an OverdoseIn this sample, 30.6% of injecting opioid users did not identify
ny risk factor for overdose, 51.3% identiﬁed one and 18.1% identi-
ed more than one. Native participants cited more frequently inad-
quate reasons for overdose, and especially the use of adulterateds (2008-2009) by number of adequate risk factors and/or actions related to opioid
or cut heroin (Figure 2a). Notably, 5.2% cited the use of the injected
route of administration as a risk factor for an opioid overdose.
In addition, 35.9% IDUs in the sample did not identify any ade-
quate action in case of witnessing an overdose, 61.1% identiﬁed one,
and only 3% identiﬁed two. Calling an emergency service (61.9%)
and giving ﬁrst aid (56.5%) were the most frequently cited adequate
actions in case of witnessing an overdose. Naloxone administra-
tion was the sixth most frequent cited adequate action, and native
participants seemed less familiar with this action (3.8%) than their
foreign peers (10.1% Eastern Europeans, 11.1% other countries). In
contrast, Eastern European participants cited very frequently the
injected administration of substances different from naloxone (typ-
ically saline or water with lemon), whereas native participants very
rarely mentioned this inadequate practice (Figure 2b).
Discussion
The main ﬁndings in the present study were: 1) Factors asso-
ciated with limited knowledge about overdose prevention were
never having attended drug dependency treatment, having a low
educational level, never having suffered an overdose, and coming
from an Eastern European country; 2) Contact with other preven-
tive resources (supervised injecting facilities, overdose prevention
courses) did not predict increased knowledge about overdose
prevention; 3) Almost 40% of respondents reported inadequate
actions in case of witnessing an overdose, and only 5.2% recognized
the injected route of administration as a risk factor for suffering
an overdose; 4) Almost three quarters of the sample had never
received training in overdose prevention.
Study limitations and strengths
This study poses the strength of exploring in detail a relevant
topic which has been poorly studied, namely knowledge about opi-
oid overdose prevention in an IDU population. Although we cannot
assure that the sample is representative of opioid injectors as a
whole in Catalonia, this study reaches a large sample out of a hid-
den population, generally very difﬁcult to access and which bears
enormous social barriers. The sample is representative of those
injecting opioid users who attended Catalonian harm reduction
centers, since assignment to strata was  proportional to the volume
of visits in each center and to the percentage of individuals in each
center by country of birth, and since sample selection was random
within the centers.
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Table  3
Predictors of limited knowledge about overdose prevention among opioid injectors recruited in Catalonian harm reduction centres, 2008-2009.
Crude Adjusted
Prevalence (%) cPR (CI95%) aPR (CI95%)
Sex
Men 27.3 0.96 (0.71-1.31) 0.87 (0.64-1.17)
Women  28.3 1 1
Age
30  or younger 28.7 1 1
31  or older 27.3 0.95 (0.71-1.31) 1.16 (0.88-1.52)
Educational level
Primary or lower 32.2 1.25 (0.97-1.62) 1.50 (1.16-1.94)*
Secondary or higher 25.7 1 1
Country of birth
Other countries 25.8 1.14 (0.81-1.60) 0.87 (0.64-1.17)
Eastern  Europe 40.3 1.78 (1.39-2.29)* 1.71 (1.29-2.26)*
Native (Spain) 22.6 1 1
Age  at ﬁrst injection
20 or younger 25.4 1
Older than 20 30.0 1.18 (0.93-1.50)
Residencea
Fixed residence 29.0 1
Institutions or homeless 24.8 0.86 (0.67-1.10)
Irregular income (marginal activities)a
No 29.7 1
Yes  26.1 0.88 (0.69-1.12)
Self-perceived healthb
Good/regular 30.6 1.36 (1.05-1.76)*
Bad 22.5 1
Length of illicit drug use
5 years or less 29.4 1
More than 5 years 27.2 0.93 (0.68-1.26)
Last drug injection
previous 30 days 28.2 1.55 (0.87-2.76)
previous 6 months 18.2 1
Frequency of drug injectiona
Daily 31.0 1.29 (1.02-1.64)*
Weekly or less 24.0 1
Supervised Injection Facilitya
Half or more of injection days 26.4 1
Less than half of injection days 29.4 1.12 (0.88-1.42)
Poly-drug usea (NOT tobacco/alcohol)
2 or less drugs 41.2 1.54 (1.01-2.34)*
3 or more drugs 26.8 1
Lifetime overdose
Yes 22.5 1 1
No  33.5 1.49 (1.18-1.89)* 1.37 (1.07-1.75)*
Lifetime overdose (n)
None 33.5 1.60 (1.02-2.50)*
between 1 and 5 22.9 1.09 (0.68-1.75)
6  or more 21.0 1
Currentb drug dependency treatment
Yes 22.2 1
No  32.8 1.48 (1.16-1.89)*
Lifetime drug dependency treatment
Yes 24.5 1 1
No  46.5 1.89 (1.47-2.44)* 1.52 (1.17-1.99)*
Lifetime overdose prevention courses
Yes 18.9 1
No  30.6 1.62 (1.18-2.23)*
a Previous 6 months.
b At time of interview.
* Statistical signiﬁcance (p<0.05).
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Figure 2. Percentages of participants mentioning each reason and action related to opioid overdose by country of birth among opioid injectors recruited in Catalonian harm
reduction centres, 2008-2009.
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l) Reasons to suffer an opioid overdose
)  Actions to undertake in case of witnessing an opioid overdose.
The dependent variable, limited knowledge about overdose pre-
ention, is not straightforward, but it is informative about those
articipants presenting reduced knowledge about overdose pre-
ention. This variable includes information about risk factors and
dequate peer assistance. There is an underreporting of well-
nown risk factors for overdose among this sample, such as using
he injected route of administration. It is possible that participants
o not identify such risk factors spontaneously, but would recog-
ize them if they would appear as a list of pre-coded questions,
s was indeed the case in another study.21 It is also possible that
articipants have taken for granted those risk factors.
imited knowledge about overdose prevention
A large proportion of participants cited consuming adulterated
r cut heroin as a risk factor for overdose, even though this is con-
idered an erroneous belief by the scientiﬁc community, as cited
lsewhere.21 It is possible that this myth is encouraged by the fact
hat prevention messages associated with concerns about purity or
mount coincide with those regarding adulterated heroin. Using a
arge amount of drug as a risk factor for suffering an opioid overdose
as the most frequently cited reason, as in other studies.12,21
Other authors21 reported a prevalence of 57.2% regarding
imited knowledge of overdose risk factors (less than two riskfactors), against our 81.9% prevalence for the same variable. This
difference could lie in the fact that our study population is older
and less educated than that making up the Itinere cohort.3,21
The role of treatment and preventive training
To be effective and to have a positive impact in knowledge, over-
dose prevention programs must achieve high coverage, reaching
most of the IDUs population.24 In Spain, harm reduction programs
were implemented during the 1990s, especially methadone main-
tenance treatment and syringe exchange programs. These were set
up later than in other EU countries, and introduction was heteroge-
neous throughout the country.25–28 Although overdose prevention
interventions had been working in Barcelona for over 8 years at the
time of the interviews,25–27 these interventions have only recently
been implemented in a systematic way.
In this study, only 27% of the participants reported ever hav-
ing attended overdose prevention courses. Even though they
presented lower prevalence of limited knowledge than their
peers, this difference was  not statistically signiﬁcant, and neither
was the association measure (adjusted prevalence ratio). Other
studies21,29,30 have reported better scores regarding overdose pre-
vention knowledge in those IDUs attending courses or IDU-oriented
resources. We would expect ﬁnding an association between
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nowledge about overdose prevention and access to health care
ervices, but in our sample, use of harm reduction resources (super-
ised injecting facilities and overdose prevention courses) does not
eem to protect against limited knowledge. However, Harm Reduc-
ion strategies have played an important role in other aspects of
ommunity health. Hence, injected drug use has overall decreased
n Spain while syringe exchange programs have been expanded.25
Interestingly, participants who had never been exposed to treat-
ent for their drug use did present signiﬁcantly higher prevalence
f limited knowledge about overdose prevention. Other stud-
es had reported that exposure to opioid maintenance treatment
educed long-term risk of overdose death.31,32 In our study, par-
icipants who had undergone previous treatment were less prone
o presenting limited knowledge. If knowledge levels translate into
dequate preventive behaviors, it is possible that, until the study
eriod, treatment centers were more efﬁcient at delivering cor-
ect information, and therefore at preventing overdose episodes,
han were overdose prevention courses. Further studies are needed
o evaluate the performance of more recently implemented, sys-
ematic overdose prevention programs. Additionally, efforts should
ontinue to make the most of those opportunities presented in each
reatment episode, further spreading preventive messages in the
ommunity.
ther Risk factors for Limited Knowledge about overdose
revention
Other individual factors associated with limited knowledge
bout overdose prevention in this study were the country of ori-
in (Eastern European countries), having a low educational level,
nd never having experienced an overdose before. IDUs who have
lready suffered non-fatal overdose episodes are more likely to be
xperienced drug users, with a history of exposure to different IDU-
riented resources including treatment and harm reduction, and
robably having received a broad array of preventive messages.
Country of origin and low educational level likely have con-
ributed a negative effect on understanding complex messages,
uch as those supplied in overdose prevention courses, since ini-
ially the content of such courses was neither provided in other
anguages nor tailored to low literacy populations. In this sense,
pecial efforts should be made to provide speciﬁc responses to IDUs
ith limited Spanish/Catalan knowledge and low literacy. In the
atalonian case, where there are higher proportions both of IDUs
nd of immigrant drug users than in other Spanish regions, ad hoc
rograms should be developed accounting for users’ speciﬁcities,
uch as idiomatic barriers and/or functional illiteracy stemming
rom a low educational level. Moreover, as the proportion of
oreign-born users in IDU-oriented resources increases, and since
mmigrants in Spain tend to make less use of health services than
atives,33,34 speciﬁcally targeted interventions should be devel-
ped to assure an increased access to such resources.
In conclusion, our ﬁndings suggest that harm reduction and
verdose prevention programs, though implemented for almost a
ecade,25–28 and though successful in many other aspects, might
ot have had a signiﬁcant impact in reducing limited knowledge
bout overdose prevention among injecting opioid users in Cat-
lonia at the time of the interviews. It is of vital importance
o continue developing extensive, methodologically systematic
verdose prevention programs, especially designed to address
diomatic, educational and cultural differences, in order to improve
nowledge about overdose prevention and to reduce potentially
armful beliefs persisting in the community. All IDU-oriented
esources should be included in such programs, particularly treat-
ent centers and harm reduction resources, in order to maximize
heir effect. Qualitative research should be undertaken to bet-
er understand the barriers to acquiring knowledge and how thisnit. 2014;28(2):146–154 153
translates into actions at overdose events among the injecting pop-
ulation. This research should then inform the development of future
overdose training programs and their evaluation.
What is already known?
Opioid overdose events are preventable and reversible,
but still account for over 6500 deaths per year in Europe.
Self-perceived general reasons for overdose and actions to
undertake if witnessing an overdose have been explored, and
can inform about the general “state of the art” regarding pre-
ventive knowledge in injecting drug users (IDUs).
What this study adds to what is known?
A restrictive variable is used which addresses limited knowl-
edge about opioid overdose prevention, hence concentrating
on the most vulnerable IDUs population.
Within the EU, Schengen Treaty allows free migration
across borders. The present study acknowledges the coun-
try of origin of participating IDUs. Achieving larger impact of
preventive measures may imply addressing this immigration
status.
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